Receives 7 observations
Indoco Remedies announced that United Kingdom - The Medicines and Healthcare Products Regulatory Agency (UK-MHRA) inspected the company's drug manufacturing facility (Plant 1 in Goa) from 14 March to 16 March 2018.Subsequent to the inspection, the UK-MHRA issued observations, which include 3 critical and 4 major.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
